IRIS - Res&Arch Institutional Research Information System - Research & Archive

CECCHETTI, Violetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.259
AS - Asia 5.890
EU - Europa 5.816
SA - Sud America 780
Continente sconosciuto - Info sul continente non disponibili 601
AF - Africa 151
OC - Oceania 15
Totale 21.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.075
SG - Singapore 2.516
IT - Italia 1.073
CN - Cina 902
UA - Ucraina 901
IE - Irlanda 869
VN - Vietnam 778
RU - Federazione Russa 736
HK - Hong Kong 734
SE - Svezia 659
BR - Brasile 602
DE - Germania 363
FI - Finlandia 270
FR - Francia 264
GB - Regno Unito 201
KR - Corea 197
IN - India 124
BE - Belgio 112
TR - Turchia 111
BD - Bangladesh 90
CA - Canada 88
JP - Giappone 81
PL - Polonia 72
MX - Messico 61
AR - Argentina 60
IQ - Iraq 54
NL - Olanda 48
RO - Romania 45
UZ - Uzbekistan 45
ZA - Sudafrica 41
CH - Svizzera 38
PK - Pakistan 38
SA - Arabia Saudita 36
ES - Italia 35
ID - Indonesia 32
AT - Austria 29
EC - Ecuador 27
CZ - Repubblica Ceca 26
PH - Filippine 25
VE - Venezuela 22
CO - Colombia 20
EG - Egitto 20
MA - Marocco 18
CL - Cile 15
LB - Libano 14
AU - Australia 13
CI - Costa d'Avorio 13
ET - Etiopia 13
MY - Malesia 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
IL - Israele 11
JO - Giordania 10
LT - Lituania 10
UY - Uruguay 10
BG - Bulgaria 9
TN - Tunisia 9
DZ - Algeria 8
GR - Grecia 8
PY - Paraguay 8
DK - Danimarca 7
EU - Europa 7
IR - Iran 7
KG - Kirghizistan 7
LV - Lettonia 7
NP - Nepal 7
PE - Perù 7
AL - Albania 6
BO - Bolivia 6
PA - Panama 6
CR - Costa Rica 5
OM - Oman 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
PT - Portogallo 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AO - Angola 3
BY - Bielorussia 3
HR - Croazia 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
LY - Libia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
Totale 20.886
Salva come PNG Salva come JPEG
Città #
Singapore 1.847
Chandler 1.091
Dublin 869
San Jose 755
Hong Kong 717
Ashburn 508
Dong Ket 487
Jacksonville 483
Perugia 469
San Mateo 460
Santa Clara 311
Boardman 307
Beijing 221
Moscow 206
Medford 205
Princeton 203
Seoul 193
Lauterbourg 178
Ann Arbor 167
Wilmington 159
Los Angeles 157
Altamura 146
Andover 128
The Dalles 125
Lawrence 123
New York 123
Brussels 112
Ho Chi Minh City 109
Munich 99
Piscataway 83
Fremont 77
Tokyo 73
Des Moines 68
Hanoi 61
São Paulo 60
Saint Petersburg 57
Turku 54
Orem 53
Dallas 51
Warsaw 48
West Jordan 48
Izmir 45
Nanjing 43
Redmond 43
Norwalk 39
Rome 37
Dearborn 36
Denver 36
Brooklyn 35
Helsinki 35
Montreal 35
Woodbridge 35
Council Bluffs 33
Atlanta 32
Chicago 29
Phoenix 29
Buffalo 28
Falls Church 28
Baghdad 26
Columbus 26
Bucharest 25
Poplar 25
Spoleto 25
Chennai 24
Hefei 24
Shanghai 24
Houston 23
San Giustino 23
Tashkent 23
London 22
San Paolo di Civitate 22
Redwood City 21
Stockholm 21
Dhaka 20
Johannesburg 20
Mexico City 20
Philadelphia 20
Seattle 20
San Diego 19
Rio de Janeiro 18
San Francisco 18
Ankara 17
Charlotte 16
Den Haag 16
Mumbai 16
Secaucus 15
Auburn Hills 14
Boston 14
Chongqing 14
Da Nang 14
Manchester 14
Milan 14
Toronto 14
Abidjan 13
Curitiba 13
Hanover 13
Olomouc 13
Porto Alegre 13
Addis Ababa 12
Amsterdam 12
Totale 13.065
Salva come PNG Salva come JPEG
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 344
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 338
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 322
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 319
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 251
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 208
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 186
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 164
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 163
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 156
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 155
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 149
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 146
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 146
New Insights on KCa3.1 Channel Modulation 146
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 145
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 144
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 144
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 144
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 143
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 142
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 141
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 140
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 139
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 136
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 136
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 136
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 136
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 136
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 135
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 133
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 130
6-Desfluoroquinolones as promising HIV transcription inhibitors 129
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 129
6-Aminoquinolones as New Potential Anti-HIV Agents 128
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 128
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 127
S. aureus NorA efflux pump: the discovery of new potent inhibitors 126
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 126
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 125
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 125
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 125
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 124
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 124
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 121
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 121
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 119
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 118
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 118
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 117
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 117
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 116
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 116
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 116
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 115
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 115
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 114
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 114
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors 114
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 113
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 113
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 113
A New Derivative with Ultra-Potent Anti-HIV Activity 112
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 111
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 111
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 110
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 109
A new 6-aminoquinolone compound with anti-HCMV activity 109
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 109
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 109
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 109
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 109
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 108
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 108
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 107
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 107
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 106
The antibacterial activity of quinolones against E.coli: a chemometric study 106
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 106
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 105
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 105
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 104
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 104
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 103
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 103
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 103
QSAR study and VolSurf characterization of anti-HIV quinolone library 102
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 102
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 101
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 101
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 101
6-Aminoquinolones targeting HCV NS5B polymerase. 99
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 98
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 98
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 98
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 97
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 96
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 96
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs 96
Totale 13.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.946 0 337 42 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20253.412 51 287 122 298 403 167 288 193 590 198 543 272
2025/20266.868 494 451 336 883 917 665 1.153 367 738 568 221 75
2026/2027304 135 169 0 0 0 0 0 0 0 0 0 0
Totale 21.512